The Middle EAST Non-Invasive Helicobacter Pylori Testing Market was valued at USD 0.25 billion in 2024 and is projected to reach USD 0.75 billion by 2034, registering a CAGR of 12.0%. This growth trajectory is underpinned by increasing awareness of gastrointestinal health, rising prevalence of H. pylori infections, and advancements in diagnostic technologies. Non-invasive testing methods, such...